Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepolizumab in Churg-Strauss Syndrome
NCT00527566Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Sep 2007
- Primary completion
- Aug 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA), sponsored by Brigham and Women's Hospital. Started Sep 2007; status: completed.
02
Drugs
mepolizumab
03
Conditions
eosinophilic granulomatosis with polyangiitis (EGPA)
Beyond the preview
Go deeper on NCT00527566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527566.